FREE WEBINAR




PAMA Cuts, the RESULTS Act, and

the Future of Lab Test Reimbursement



Aired On November 12, 2025 at 1pm EST


Watch On Demand

60-Minute Webinar with Live Q&A

Join us to gain the insights you need to navigate upcoming changes, influence the conversation on Capitol Hill, and safeguard your lab’s financial future.

Sponsored by:

Synergen_Logo-Large-1

istockphoto-467571490-170667a legislation

 

 

Prepare Your Lab for What’s Coming in 2026

 

Medicare reimbursement cuts are looming again. On January 1, 2026, clinical laboratories across the country will face another round of reductions under the Protecting Access to Medicare Act (PAMA)—unless Congress acts. The newly introduced RESULTS Act could change everything.

Join us for a timely, nonpartisan webinar that breaks down the RESULTS Act, its potential to reshape lab reimbursement, and what your organization can do to prepare and advocate.

Register now for this free 60-minute webinar, “PAMA Cuts, the RESULTS Act, and the Future of Lab Test Reimbursement,” which aired on November 12, 2025. 

After attending this webinar, participants will be able to:

 
  • Explain the key provisions of the RESULTS Act and how they interact with PAMA’s current reimbursement mandates.

  • Understand how Medicare establishes clinical laboratory test payment rates and why those rates have trended downward.

  • Identify concrete steps labs can take to advocate for the RESULTS Act and prepare financially for possible outcomes.

susan-van-meter

 

thumbnail_IMG_2994 (002)

 

Susan Van Meter

President, American Clinical Laboratory Association (ACLA)

Susan Van Meter serves as President of the American Clinical Laboratory Association (ACLA), the national trade association representing leading clinical laboratories across the United States. She assumed the role in March 2022, bringing with her a wealth of experience in health policy, advocacy, and regulatory affairs. Before joining ACLA, Van Meter was Executive Director of AdvaMedDx, where she led strategic initiatives for manufacturers of in vitro diagnostic (IVD) clinical tests. Her leadership was instrumental in shaping the association’s response to the COVID-19 pandemic and advancing policy efforts to support diagnostic innovation. Earlier in her career, Van Meter held the position of Senior Vice President of Federal Relations at the Healthcare Association of New York State (HANYS), advocating for hospitals and health systems. She also worked within the Centers for Medicare & Medicaid Services’ Office of Legislation, contributing to federal healthcare policy development.

 

Jay Weiss, Ph.D.
President and Co-Owner, Allermetrix

Jay is the president and co-owner of Allermetrix, Inc., an allergy specialty laboratory. He is past president of American Association of Bioanalysts (AAB) and National Independent Laboratory Association (NILA).

Jay has spent 20 years in the immunodiagnostic industry and 25 years in the clinical laboratory services sector. He has focused his work in immunodiagnostics with an emphasis in allergy serology.

 

 

 

 

 

 

Who should attend?

  • Laboratory directors and administrators
  • Healthcare policy advocates
  • Billing and reimbursement professionals
  • Anyone impacted by Medicare lab test payment rates
Watch On Demand

Hosted By

dark daily logo-no tags-FIT-white